Antidepressant-like effects of δ opioid receptor agonists in animal models
A Saitoh, M Yamada - Current neuropharmacology, 2012 - ingentaconnect.com
Recently, δ opioid receptor agonists have been proposed to be attractive targets for the
development of novel antidepressants. Several studies revealed that single treatment of δ …
development of novel antidepressants. Several studies revealed that single treatment of δ …
Essential role of brain-derived neurotrophic factor in the regulation of serotonin transmission in the basolateral amygdala
SS Daftary, G Calderon, M Rios - Neuroscience, 2012 - Elsevier
Human and animal model studies have linked brain-derived neurotrophic factor (BDNF) with
the etiology of anxiety disorders. This pleiotropic neurotrophin and its receptor, TrkB …
the etiology of anxiety disorders. This pleiotropic neurotrophin and its receptor, TrkB …
Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the …
S Kim, K Zavitsanou, G Gurguis, MJ Webster - European …, 2012 - Elsevier
The atypical antipsychotics bind multiple receptor targets, including dopamine D2 receptors
(DRD2), 5-HT2 receptors (HTR2A), α-2 adrenergic receptors (ADRA2A), and muscarinic …
(DRD2), 5-HT2 receptors (HTR2A), α-2 adrenergic receptors (ADRA2A), and muscarinic …
Efectos de fluoxetina sobre las sinapsis excitadoras telencefálicas y sobre modelos de depresión inducida por estrés
EM Ampuero Llanos - 2012 - repositorio.uchile.cl
En la depresión mayor, la remisión de los síntomas depresivos mediante el uso de fármacos
antidepresivos (FADs) requiere de la administración prolongada de éstos. El retardo …
antidepresivos (FADs) requiere de la administración prolongada de éstos. El retardo …